Lightning.AI
Think. See. Learn.
Biology at AI scale
lightning icon

The first discovery platform where Computational and Experimental AI work in a continuous loop to uncover biology, discover targets and drugs, and accelerate breakthrough therapies.

The Future of Drug Discovery Isn’t Predicted - It’s Seen

Biology speaks in pathways - not endpoints or clusters.

Lightning AI visualizes disease in motion, inside real cells - revealing what drives it and how to intervene.

Two AIs. One Discovery Loop.

Not a lab in a loop.

Lightning AI connects Computational and Experimental AI in a continuous feedback loop - each generating and refining insight.

Iterative discovery that learns, improves, and converges on what matters.

Computational AIHypotheses at Scale

Our Computational AI integrates multi-omics, literature, and customer data to generate thousands of mechanistic hypotheses per disease.

It prioritizes pathways likely to drive disease and frames the key questions for exploration.

Experimental AIVisualizing, Learning, Refining

Experimental AI doesn’t test - it sees. It visualizes each hypothesis across millions of healthy and diseased cells, revealing pathway behavior, functional phenotypes, and biological signals.

It learns from what it sees - and feeds that insight back into the loop.

PathwayLight™

From 1,000 Hypotheses to 1 Billion Experiments - Instantly

Thousands of hypotheses. Millions of patient-derived cells.

Every hypothesis explored in parallel - over a billion experiments in a single run.

Discovery at AI scale.

PathwayLight™ - Biology You Can See

PathwayLight™ visualizes how thousands of pathways behave inside real cells.

Not morphology. Not surface phenotype.

This is imaging at the level of biological function - pathways, not shapes.

Morphology is sign language. Pathways are the native language of biology.

  • Transcription
  • Splicing
  • Alternative splicing
  • Capping
  • Polyadenylation
  • Modification
  • Nuclear Export
  • Transport
  • Localization
  • Stability
  • Decay
  • Translation

PathwayLight Neural Network - The AI Inside the Biology

Trained on billions of images, this neural network compares healthy and diseased cells millions of times for every hypothesis.

It identifies dysregulation, recognizes phenotypes, and drives the discovery loop forward.

Visualizing the Full Complexity of Disease

Diseases live in systems, not single cells. Lightning AI visualizes biology from tissue context to individual cells, adapting to each disease model.

Complexity, captured at the right resolution.

Target Discovery

A Discovery Loop That Delivers Novel, Yet Druggable Targets

This isn’t biology for exploration’s sake.

The loop is built to deliver druggable targets - novel, mechanistically defined, and directly linked to disease biology.

Targets the system sees, understands, and enables you to act on.

Validating Targets with Visual Pathway Knockouts

Target confidence matters.

Lightning AI applies a proprietary method of Visual Pathway Knockouts - disrupting the target’s pathway and observing biological consequences at scale.

The effect is seen, not inferred - validating both pathway and target in full biological context.

Drug Discovery

mRNA Biology Neural Network - From Target to Modulation

Trained on mRNA regulation across thousands of pathways, the second neural network explores each target’s mRNA biology. It identifies modulation strategy through splicing, RBPs, localization, degradation or translation.

Modulation by mechanism, not guesswork.

neaural network

Drug Discovery

Chemistry That Targets the Target

Once a modulation strategy is identified, Lightning AI generates a focused small molecule library designed to act through the specific biology of the target.

As compounds are screened, the neural network visualizes their effect on disease pathways in real cells - confirming impact and optimizing intervention.

Drugging the biology, not just the target.

A Proprietary Data Engine: The Visual Biology of Disease

Lightning AI generates a new class of biological data: functional, spatial, and visual.
This data doesn’t exist in omics.
It becomes your exclusive, proprietary advantage.


Our Partners

We work with pharma and technology leaders to transform how new drugs are discovered.
If you build platforms, run infrastructure, or drive pipelines write to [email protected].
Let’s talk!

Let’s Redefine What’s Possible

Not predicted. Not validated. Discovered.

Two AIs. One loop. From biology to targets to drugs.